Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - montelukast sodium - tablets chewable - 5 milligram

Malta - English - Medicines Authority

merck sharp & dohme limited hertford road, hoddesdon, hertfordshire en11 9bu, united kingdom - ethinylestradiol, etonogestrel - vaginal delivery system - ethinylestradiol 2.7 milligram(s) ; etonogestrel 11.7 milligram(s) - other gynecologicals

Malta - English - Medicines Authority

merck sharp & dohme limited - varicella virus oka/merck strain (live, attenuated) - powder and solvent for suspension for injection - varicella virus oka/merck strain (live, attenuated) - vaccines

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck sharp & dohme ltd - varicella-zoster virus live attenuated (oka/merck strain) - powder and solvent for suspension for injection

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - water for injections, quantity: 0.85 ml - diluent, not applicable - excipient ingredients: - this product approved for registration as an amendment to a product accepted for inclusion in the artg as 'currently supplied' at the commencement of the therapeutic goods act 1989. indications are held in artg paper records. (old code)

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - rotavirus g1 reassortant; rotavirus g2 reassortant; rotavirus g3 reassortant; rotavirus g4 reassortant; rotavirus p1a[8] reassortant - oral solution - rotavirus p1a[8] reassortant 2.3 x10 ^6 iu/dose; rotavirus g2 reassortant 2.8 x10 ^6 iu/dose; rotavirus g4 reassortant 2.0 x10^ 6 iu/dose; rotavirus g3 reassortant 2.2 x10 ^6 iu/dose; rotavirus g1 reassortant 2.2 x10 ^6 iu/dose - rota virus diarrhea vaccines - rotateq is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by types g1, g2, g3, g4, and g9 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks. the first dose of rotateq should be administered between 6 and 12 weeks of age

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - measles virus enders edmonston strain (live, attenuated); mumps virus jeryl lynn™ (level b) strain (live, attenuated); rubella virus wistar ra 27/3 strain (live, attenuated); varicella virus oka/merck strain (live, attenuated) - powder and solvent for suspension for injection - measles virus enders edmonston strain (live, attenuated); varicella virus oka/merck strain (live, attenuated); rubella virus wistar ra 27/3 strain (live, attenuated); mumps virus jeryl lynn™ (level b) strain (live, attenuated) - measles, combinations with mumps, rubella and varicella, live attenuated - proquad is indicated for simultaneous vaccination against measles, mumps, rubella, and varicella in individuals from 12 months of age to 12 years of age.proquad can be administered to individuals from 9 months of age under special circumstances: outbreak situations, or travel to a region with high prevalence of measles.

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - fosaprepitant dimeglumine 197.5mg ((free acid) (120.8 mg)) - powder for injection - 115 mg - active: fosaprepitant dimeglumine 197.5mg ((free acid) (120.8 mg)) excipient: disodium edetate hydrochloric acid lactose polysorbate 80 sodium hydroxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - fosaprepitant dimeglumine 257.6mg ((free acid) (157.5 mg)) - powder for injection - 150 mg - active: fosaprepitant dimeglumine 257.6mg ((free acid) (157.5 mg)) excipient: disodium edetate hydrochloric acid lactose polysorbate 80 sodium hydroxide water for injection - indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: · highly emetogenic cancer chemotherapy · moderately emetogenic cancer chemotherapy in combination with other antiemetic agents.

Israel - English - Ministry of Health

merck sharp & dohme israel ltd - cilastatin sodium; imipenem as monohydrate - powder for solution for infusion - cilastatin sodium 500 mg/vial; imipenem as monohydrate 500 mg/vial - imipenem and enzyme inhibitor - imipenem and enzyme inhibitor - 1.1 lower respiratory tract infectionstienam for intravenous use is indicated for the treatment of lower respiratory tract infections caused by susceptible strains of staphylococcus aureus (penicillinase-producing isolates), acinetobacter species, enterobacter species, escherichia coli, haemophilus influenzae, haemophilus parainfluenzae, klebsiella species, serratia marcescens.1.2 urinary tract infections (complicated and uncomplicated) tienam is indicated for the treatment of urinary tract infections (complicated and uncomplicated) caused by susceptible strains of enterococcus faecalis, staphylococcus aureus (penicillinase-producing isolates), enterobacter species, escherichia coli, klebsiella species, morganella morganii, proteus vulgaris, providencia rettgeri, pseudomonas aeruginosa.1.3 intra-abdominal infections tienam is indicated for the treatment of intra-abdominal infections caused by susceptible strains of enterococcus faecalis, staphylococcus aureus (penicillinase-producing isolates), staphylococcu